Inactief instrument

Andere talen Biostar Pharmaceuticals Inc Nasdaq

Aandelen

US0906782026

slotkoers Nasdaq Andere beurzen
- ^USD	-

2023	Biostar Pharmaceuticals, Inc. Kondigt FDA Goedkeuring aan van Utidelone Injectable (UTD1) Fase 2/3 Multi-Nationale Klinische Studie voor Niet-Kleincellige Longkanker	CI
2023	Biostar Pharma, Inc. kondigt aan dat de eerste patiënt is ingeschreven voor de Fase 1 studie van Utidelone Capsule (Utd2)	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Biostar Pharmaceuticals, Inc. Announces FDA Approval of Utidelone Injectable Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer	15-06-23
Biostar Pharma, Inc. Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule	12-06-23
Waiping Liu cancelled the acquisition of 16.2% stake in Biostar Pharmaceuticals, Inc. from Ronghua Wang.	02-06-19
Biostar Pharmaceuticals, Inc.(NasdaqCM:BSPM) dropped from NASDAQ Composite Index	18-09-18
Waiping Liu Discloses its Plans on Biostar Pharmaceuticals	02-07-18
Waiping Liu entered into share purchase agreement to acquire 16.2% stake in Biostar Pharmaceuticals, Inc. from Ronghua Wang for $0.67 million.	02-07-18
Biostar Pharmaceuticals, Inc. Announces Board Changes	02-02-18
Biostar Pharmaceuticals, Inc. Appoints Melissa Fan Chen as an Independent Member of the Board and the Chair of the Audit Committee	28-12-17
Biostar Pharmaceuticals, Inc. Announces Resignation of Leung King Fai as an Independent Director	18-12-17
Biostar Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017	20-11-17
Biostar Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017	15-11-17
Biostar Pharmaceuticals Seeks Acquisitions	15-11-17
Biostar Pharmaceuticals, Inc. cancelled the acquisition of Xianyang Yongsheng Health Products Co., Ltd.	07-09-17
Biostar Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2017	19-05-17
Biostar Pharmaceuticals, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2016	13-04-17
Biostar Pharmaceuticals, Inc. Announces Management Changes	09-02-17
Biostar Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016	21-11-16
Biostar Pharmaceuticals, Inc. to Launch New Product Aimed at Treating Effects of Rhinitis and Sinusitis	11-10-16
Biostar Pharmaceuticals, Inc. executed a non-binding letter of intent to acquire Xianyang Yongsheng Health Products Co., Ltd.	22-09-16
Biostar Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016	22-08-16

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biostar Pharmaceuticals Inc Nasdaq

Aandelen

US0906782026

Andere talen

Filters